(550 Results)
Filter
What are you looking for?
-
Category
-
Type
-
Year
-
Keywords
-
Author
Apply filters
Knowledge Hub
Collapse
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
Molecular Allergology User's Guide 2.0The First Edition of “EAACI Molecular Allergology User’s Guide” was released in 20...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA position paperAbstract Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT16...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic - An EAACI/ARIA position paperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
ERS/EAACI statement on adherence to international adult asthma guidelinesAbstract Guidelines aim to standardise and optimise asthma diagnosis and management. Neve...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
Show more Consensus Documents (9)Show Less-
-
Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: An ARIA-EAACI statementA novel strain of human coronaviruses, named by the International Committee on Taxonomy of...
-
Pollen season is reflected on symptom load for grass and birch pollen-induced allergic rhinitis in different geographic areas - An EAACI Task Force ReportAbstract Background: The effectiveness of allergen immunotherapy (AIT) in seasonal and ...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensusAbstract Background: Although there are many asymptomatic patients, one of the problems ...
-
EAACI position paper on the clinical use of the bronchial allergen challenge: Unmet needs and research prioritiesAbstract Allergic asthma (AA) is a common asthma phenotype, and its diagnosis requires bo...
-
Cannabis-related allergies: an international overview and consensus recommendationsAbstract Cannabis is the most widely used recreational drug in the world. Cannabis sativa ...
-
The urgent need for a harmonized severity scoring system for acute allergic reactionsAbstract The accurate assessment and communication of the severity of acute allergic reac...
-
Allergies and COVID-19 vaccines: An ENDA/ EAACI Position paperAbstract Background: Anaphylaxis, which is rare, has been reported after COVID-19 vacci...
-
Current practice of allergy diagnosis and the potential impact of regulation in EuropeAbstract In the European Union (EU), the regulatory framework regarding diagnostic allerg...
-
Management of ocular allergyAbstract The treatment and management of ocular allergy (OA) remain a major concern for d...
-
EAACI Position paper on the standardization of nasal allergen challengesAbstract Nasal allergen challenge (NAC) is an important tool to diagnose allergic rhiniti...
-
Emerging roles of innate lymphoid cells in inflammatory diseases: Clinical implicationsAbstract Innate lymphoid cells (ILC) represent a group of lymphocytes that lack specific ...
-
Omics technologies in allergy and asthma research: An EAACI position paperAbstract Allergic diseases and asthma are heterogenous chronic inflammatory conditions wit...
-
Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statementAbstractThe current COVID-19 pandemic influences many aspects of personal and social in-te...
-
Dangerous liaisons: bacteria, antimicrobial therapies and allergic diseasesAbstract Microbiota composition and associated metabolic activities are essential for the...
-
Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paperAbstract Because of the inflammatory mechanisms of most chronic upper airway diseases suc...
-
The One Health approach for allergic diseases and asthmaAbstract The One Health approach is a collaborative and interdisciplinary strategy with f...
-
Delayed hypersensitivity to antiepileptic drugs in childrenAbstract Background: Antiepileptic drugs (AEDs) are widely used for the treatment of ep...
-
EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitisAbstract The prevalence of allergic diseases such as allergic rhinitis, asthma, food alle...
-
Biologicals in atopic disease in pregnancy: An EAACI position paperAbstract Biologicals have transformed the management of severe disease phenotypes in asth...
-
Placebo effects in allergen immunotherapy - An EAACI Task Force Position PaperAbstract The placebo (Latin “I will please”) effect commonly occurs in clinic...
-
Food processing and occupational respiratory allergy- An EAACI position paperAbstract Occupational exposure to foods is responsible for up to 25% of cases of occupati...
-
Allergen immunotherapy in people, dogs, cats and horses – differences, similarities and research needsAbstract In human patients with seasonal allergic rhinoconjunctivitis sensitized to grass...
-
The role of mobile health technologies in allergy care: An EAACI position paperAbstract Mobile health (mHealth) uses mobile communication devices such as smartphones an...
-
An EAACI Task Force report on allergy to beta-lactams in children: Clinical entities and diagnostic proceduresAbstract Beta-lactam (BL) allergy suspicion is common in children and constitutes a major...
-
Allergic and hypersensitivity conditions in non-specialist care: Flow diagrams to support clinical practiceAbstract Most patients presenting with allergies are first seen by primary care health pr...
-
COVID-19 vaccination in patients receiving allergen immunotherapy (AIT) or biologicals – EAACI recommendationsAbstract Immune modulation is a key therapeutic approach for allergic diseases, asthma an...
-
Diagnosis and management of Non-IgE gastrointestinal allergies in breastfed infants - An EAACI Position PaperAbstract It is well-established that food proteins, such as egg, soya, cow’s milk a...
-
Respiratory diseases and allergy in farmers working with livestock: a EAACI position paperAbstract Farmers constitute a large professional group worldwide. In developed countries ...
-
Noninvasive and minimally invasive techniques for the diagnosis and management of allergic diseasesAbstract Allergic diseases of the (upper and lower) airways, the skin and the gastrointes...
-
Diagnosis and management of allergy and respiratory disorders in sport: An EAACI task force position paperAbstract Allergy and respiratory disorders are common in young athletic individuals. In t...
-
European Academy of Allergy and Clinical Immunology position paper on endoscopic scoring of nasal polyposisAbstract Nasal endoscopy is not only used for the diagnosis of chronic rhinosinusitis wit...
-
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paperAbstract The high prevalence of allergic diseases warrants for sufficient health care pro...
-
Technical standards in allergen exposure chambers worldwide - an EAACI Task Force ReportAbstract Allergen exposure chambers (AECs) can be used for controlled exposure to allerge...
-
ARIA-EAACI statement on severe allergic reactions to COVID-19 vaccines – an EAACI-ARIA Position PaperAbstract Further to the approval of the Coronavirus disease 2019 (COVID-19) vaccine BNT16...
-
Genetic variants associated with T cell-mediated cutaneous adverse drug reactions: A PRISMA-compliant systematic review - An EAACI position paperAbstract Drug hypersensitivity reactions (DHRs) are associated with high global morbidity...
-
A EAACI drug allergy interest group survey on how European allergy specialists deal with β-lactam allergyAbstract An accurate diagnosis of β-lactam (BL) allergy can reduce patient morbidity and...
-
A multi-disciplinary approach to the diagnosis and management of allergic disease: An EAACI Task ForceAbstract Background: Guidelines for management of patients with allergic conditions are...
-
Management of patients with chronic rhinosinusitis during the COVID-19 pandemic-An EAACI position paperAbstract Background: Chronic rhinosinusitis is regarded as a chronic airway disease. Acc...
-
Gender and occupational allergy: Report from the task force of the EAACI Environmental and Occupational Allergy Interest GroupAbstract Women’s work has traditionally been considered less hazardous to health in...
-
In-vivo diagnostic test allergens in Europe: A call to action and proposal for recovery plan - An EAACI position paperAbstract Diagnostic allergens are defined as medicinal products in the EU. Marketing auth...
-
AllergoOncology: Microbiota in allergy and cancer - A European Academy for Allergy and Clinical Immunology position paperAbstract The microbiota can play important roles in the development of human immunity and...
-
Allergen immunotherapy: The growing role of observational and randomized trial "Real-World Evidence"Abstract Background: Although there is a considerable body of knowledge about allergen ...
-
Diagnosis and management of food allergy-associated gastroesophageal reflux disease in young children - EAACI position paperAbstract Gastro-oesophageal reflux (GOR) and food allergy (FA) are common conditions, esp...
-
Role of dietary fiber in promoting immune health - An EAACI position paperAbstract Microbial metabolism of specific dietary components, such as fiber, contributes ...
-
Practice parameters for diagnosing and managing iodinated contrast media hypersensitivityAbstract Immediate and nonimmediate hypersensitivity reactions to iodinated contrast medi...
-
AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancerAbstract While desired for the cure of allergy, regulatory immune cell subsets and noncla...
-
Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paperAbstract Introduction In allergic asthma patients, one of the more common phenotypes might...
-
The roadmap for allergology in Europe: The subspecialty of allergology as “stop-over” on the way to a full specialty. An EAACI position statementAbstract The vision of European Academy of Allergy and Clinical Immunology (EAACI) and th...
-
AllergoOncology: ultra-low IgE, a potential novel biomarker in cancer - a Position Paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Elevated serum IgE levels are associated with allergic disorders, parasitosis an...
-
Hypersensitivity reactions to chemotherapy: an EAACI position paperAbstract Chemotherapeutic drugs have been widely used in the treatment of cancer disease ...
-
Current perspective on eicosanoids in asthma and allergic diseases: EAACI Task Force consensus report, part IAbstract Eicosanoids are biologically active lipid mediators, comprising prostaglandins, ...
-
Hypersensitivity reactions to biological agents: An EAACI position paperAbstract Biologicals are crucial targeted therapeutic agents in oncological, immunologica...
-
Skin microdialysis: methods, applications and future opportunities - an EAACI position paperAbstract Skin microdialysis (SMD) is a versatile sampling technique that can be used to r...
-
Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paperAbstract Drug hypersensitivity reactions (DHR) constitute a major and common public healt...
-
Alpine Altitude Climate Treatment for severe and uncontrolled asthma: an EAACI Position PaperAbstract Currently available European Alpine Altitude Climate Treatment (AACT) programs co...
-
Comparing biologicals and small molecule drug therapies for chronic respiratory diseases: An EAACI Taskforce on Immunopharmacology position paperAbstract Chronic airway diseases such as asthma and chronic obstructive pulmonary disease...
-
Perceptions of adolescents and young adults with allergy and/ or asthma and their parents on EAACI guideline recommendations about transitional care: A European surveyAbstract Background: The European Academy of Allergy and Clinical Immunology has develo...
-
Towards a more precise diagnosis of hypersensitivity to beta-lactams - an EAACI position paperAbstract A recent survey of the European Academy of Allergy and Clinical Immunology (EAAC...
-
Current allergy educational needs in primary care. Results of the EAACI working group on primary care survey exploring the confidence to manage and the opportunity to refer patients with allergyAbstract The aim of this survey was to explore the specific educational needs of a cohort...
-
The development of birch pollen seasons over 30 years in Munich, Germany - An EAACI task force reportThe global warming–oriented climate change is able to induce changes in the presentation...
-
Health effects of exposure to chlorination by - products in swimming poolsAbstract Concerns have been raised regarding the potential negative effects on human heal...
-
A practical toolbox for the effective transition of adolescents and young adults with asthma and allergies: An EAACI position paperAbstract Introduction: Adolescence is a critical stage of rapid biological, emotional a...
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccinesAbstract The first approved COVID-19 vaccines include Pfizer/BioNTech BNT162B2, Moderna m...
-
Considerations on biologicals for patients with allergic disease in times of the COVID-19 pandemic: An EAACI statementAbstract The outbreak of the SARS-CoV-2-induced coronavirus disease 2019 (COVID-19) pande...
-
EAACI position paper on diet diversity in pregnancy, infancy and childhood: Novel concepts and implications for studies in allergy and asthmaAbstract To fully understand the role of diet diversity on allergy outcomes and to set st...
-
Toward clinically applicable biomarkers for asthma: An EAACI position paperAbstract Inflammation, structural, and functional abnormalities within the airways are ke...
-
A European survey of management approaches in chronic urticaria in children: EAACI Paediatric Urticaria TaskforceAbstract Background: Although well described in adults, there are scarce and heterogene...
-
COVID-19 pandemic: Practical considerations on the organization of an allergy clinic-An EAACI/ ARIA Position PaperAbstract Background: The coronavirus disease 2019 (COVID-19) has evolved into a pandemic...
-
AllergoOncology: Danger signals in allergology and oncology: A European Academy of Allergy and Clinical Immunology (EAACI) Position PaperAbstract The immune system interacts with many nominal ‘danger’ signals, endo...
-
Proposal of 0.5 mg of protein/100 g of processed food as threshold for voluntary declaration of food allergen traces in processed food-A first step in an initiative to better inform patients and avoid fatal allergic reactions: A GA²LEN position paperAbstract Background: Food anaphylaxis is commonly elicited by unintentional ingestion o...
-
Preliminary pilot study results of the EAACI allergy educational needs in primary care pediatricians Task Force in managing allergic disordersREAD HERE
-
Prioritizing research challenges and funding for allergy and asthma and the need for translational research - The European Strategic Forum on Allergic DiseasesAbstract The European Academy of Allergy and Clinical Immunology (EAACI) organized the fi...
-
Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapyAbstract Purpose: The European Academy of Allergy and Clinical Immunology (EAACI) has p...
-
State-of-the-art in marketed adjuvants and formulations in Allergen Immunotherapy: A position paper of the European Academy of Allergy and Clinical Immunology (EAACI)Abstract Since the introduction of allergen immunotherapy (AIT) over 100 years ago, focus...
-
Fungal exposome, human health, and unmet needs: A 2022 update with special focus on allergyAbstract Humans inhale, ingest, and touch thousands of fungi each day. The ubiquity and d...
-
Exercise and physical activity for asthma management: The European Academy of Allergy and Clinical Immunology perspectiveAsthma is a complex heterogeneous disease characterized by bronchial hyperresponsiveness (...
-
Emerging concepts and challenges in implementing the exposome paradigm in allergic diseases and asthma: a Practall documentAbstract Exposome research can improve the understanding of the mechanistic connections b...
-
Immune modulation via T regulatory cell enhancement: Disease-modifying therapies for autoimmunity and their potential for chronic allergic and inflammatory diseases—An EAACI position paper of the task force on immunopharmacology (TIPCO)Abstract Therapeutic advances using targeted biologicals and small-molecule drugs have ac...
-
Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paperAbstract NSAID-exacerbated respiratory disease (N-ERD) is a chronic eosinophilic, inflamm...
-
Management of anaphylaxis due to COVID-19 vaccines in the elderlyAbstract Older adults, especially men and/or those with diabetes, hypertension, and/or ob...
-
EAACI position paper on how to classify cutaneous manifestations of drug hypersensitivityAbstract Drug hypersensitivity reactions (DHRs) are common, and the skin is by far the mo...
-
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentAbstract Insect venom allergy is the most frequent cause of anaphylaxis in Europe and poss...
-
An EAACI position paper on the investigation of perioperative immediate hypersensitivity reactionsAbstract Perioperative immediate hypersensitivity reactions are rare. Subsequent allergy ...
-
Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies—Report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforceAbstract Background Although it has been shown that allergen immunotherapy (AIT) is well-t...
-
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach – ARIA-EAACI Task Force ReportAbstract Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis a...
Show more Position Papers (83)Show Less-
-
Angiotensin‐converting enzyme II expression and its implication in the association between COVID‐19 and allergic rhinitisIn conclusion, for the first time, we provide the evidence that AR comorbidity may not hav...
-
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold - an ARIA- EAACI - GA2LEN consensusAlthough there are many asymptomatic patients, one of the problems of COVID‐19 is early ...
-
Regional differences in ACE2 expression in the sinonasal mucosa of adult Chinese patients with chronic rhinosinusitisIn summary, our study provides the first evidence of regional differences in ACE2 expressi...
-
Immunological imprint of COVID-19 on human peripheral blood leukocyte populationsSARS‐CoV‐2 has triggered a pandemic that is now claiming many lives. Several studies h...
-
Is there a role for childhood vaccination against COVID-19?Tremendous efforts are undertaken to quickly develop COVID‐19 vaccines that protect vuln...
-
African American children are at higher risk for COVID‐19 infection“Infection by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the ...
-
COVID-19 Pandemic and allergen immunotherapy - an EAACI surveyAs in many fields of medical care, the coronavirus disease 2019 (COVID‐19) resulted in a...
-
ARIA‐EAACI statement on severe allergic reactions to COVID‐19 vaccines – an EAACI‐ARIA position paperCoronavirus disease 2019 (COVID‐19) vaccine BNT162b2 received approval and within the fi...
-
Vaccines and allergic reactions: the past, the current COVID‐19 pandemic, and future perspectivesAbstract Vaccines are essential public health tools with a favorable safety profile and pr...
-
Blood myeloperoxidase‐DNA, a biomarker of early response to SARS‐CoV‐2 infection?In conclusion, our results on a consecutive ambulatory population of COVID‐19 cases sugg...
-
Bacillus Calmette‐Guérin vaccination and socioeconomic variables vs COVID‐19 global features: Clearing up a controversial issueTo the best of our knowledge, this is the first study assessing at the global level the im...
-
Management of patients with chronic rhinosinusitis during the COVID‐19 pandemic - An EAACI Position PaperIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS‐C...
-
Risk factors for severe and critically ill COVID-19 patients: A reviewIntranasal corticosteroids remain the standard treatment for CRS in patients with SARS‐C...
-
Atopic status protects from severe complications of COVID‐19In conclusion, atopic status seems to protect against the most severe, often fatal consequ...
-
Antibody dynamics to SARS‐CoV‐2 in asymptomatic COVID‐19 infectionsOur findings might have important implications for the definition of asymptomatic COVID‐...
-
Elastase and Exacerbation of Neutrophil Innate Immunity are Involved in Multi‐Visceral Manifestations of COVID‐19Many arguments suggest that neutrophils could play a prominent role in COVID‐19. However...
-
Managing childhood allergies and immunodeficiencies during respiratory virus epidemics – the 2020 COVID‐19 pandemic - A statement from the EAACI-Section on PediatricsMost countries affected by COVID‐19 have opted for nationwide confinement, which means t...
-
The global impact of the COVID-19 pandemic on the management and course of chronic urticariaThe COVID‐19 pandemic dramatically disrupts health care around the globe. The impact of ...
-
Delayed virus‐specific antibody responses associate with COVID‐19 mortalityCollectively, for the first time, our study provides evidence that delayed antibody respon...
-
The younger the milder clinical course of COVID-19 - even in infants? Neonates appeared to bear more severe clinical courses. In addition to higher case fatalit...
-
Asthma control, self‐management and healthcare access during the COVID‐19 epidemic in BeijingThe results support the recommendation that patients continue taking their prescribed asth...
-
EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID‐19 vaccinesWe provide a simplified algorithm of prevention, diagnosis and treatment of severe allergi...
-
A male infant with COVID-19 in the context of ARPC1B DeficiencyThe current pandemic of the novel SARS‐CoV‐2 infection has affected over 10 million hu...
-
The first, holistic immunological model of COVID‐19: Implications for prevention, diagnosis, and public health measuresThis allows the virus to bypass the efficient immune barrier of the upper airway mucosa in...
-
Cabbage and fermented vegetables: from death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID‐19The nuclear factor (erythroid‐derived 2)‐like 2 (Nrf2) is the most potent antioxidant ...
-
A Global Effort to Define the Human Genetics of Protective Immunity to SARS-CoV-2 InfectionSARS-CoV-2 infection displays immense inter-individual clinical variability, ranging from ...
-
World Allergy Organization (WAO): Preparing your office for the COVID-19 PandemicAs COVID-19 continues to spread, it is important that we are ready to continue to care for...
-
Skin tests in urticaria/angioedema and flushing to Pfizer‐BioNTech SARS‐CoV‐2 vaccine: limits of intradermal testingDuring clinical approval studies and early post‐marketing phases, mucous‐cutaneous adv...
-
APOE e4 Genotype Predicts Severe COVID-19 in the UK Biobank Community CohortThis interesting article shows that the ApoE e4e4 allele increases risks of severe COVID-1...
-
Allergic reactions to the first COVID‐19 vaccine: a potential role of polyethylene glycol?The COVID‐19 vaccine developed by Pfizer and BioNTech was approved by the Medicines and ...
-
COVID-19: Pandemic Contingency Planning for the Allergy and Immunology ClinicIn the event of a global infectious pandemic, drastic measures may be needed that limit or...
-
Genetic Predisposition to allergic diseases is inversely associated to risk of COVID-19Allergic diseases such as allergic rhinitis (hay fever), atopic dermatitis (eczema) and as...
-
Position statement of expert panel of the Polish Allergology Society (PTA) on the management of patients with bronchial asthma and allergic diseases during the SARS-CoV-2 pandemicThe dynamically changing epidemiological situation related to SARS-CoV-2 infection poses c...
-
Accuracy of serological testing for SARS‐CoV‐2 antibodies: first results of a large mixed‐method evaluation studyELISAs targeting RBD and S1 protein of SARS‐CoV‐2 are promising immunoassays which sha...
-
Genome-wide CRISPR screen reveals host genes that regulate SARS-CoV-2 infectionWe also revealed that the alarmin HMGB1 is critical for SARS-CoV-2 replication. In contras...
-
Real‐life impact of COVID‐19 pandemic lockdown on the management of pediatric and adult asthma: a survey by the EAACI Asthma SectionAbstract Background The restrictions imposed by the COVID-19 pandemic impact heavily the m...
-
Detection of SARS‐CoV‐2 Specific Memory B cells to Delineate Long‐Term COVID‐19 ImmunityOur study performed on a central-European cohort is in line with the data on the recently ...
-
Distinct expression of SARS- CoV-2 receptor ACE2 correlates with endotypes of rhinosinusitis with nasal polyps“Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) entry factors, ACE...
-
Impact of anxiety, stress and depression related to COVID-19 pandemic on the course of hereditary angioedema with C1 inhibitor deficiencyHereditary angioedema (HAE) attacks can be provoked with psychological factors. The aim of...
-
Allergenic components of the mRNA‐1273 vaccine for COVID‐19: possible involvement of polyethylene glycol and IgG‐mediated complement activationFollowing the emergency use authorization of the mRNA‐1273 vaccine on the 18thof Decembe...
Show more Covid-19 (38)Show Less-
-
Immune modulation in local allergic rhinitis
-
MP-AzeFlu improves quality of life of patients with allergic rhinitis: A real-world study
-
Allergen immunotherapy for rhinitis phenotypes other than allergic rhinitis: mixed rhinitis and local allergic rhinitis
-
Potential usefulness of in-vitro tools for identifying aeroallergens sensitization in suspected local allergic rhinitis
-
Assessment of efficacy of allergen immunotherapy in patients with allergic rhinitis and atopic asthma
-
Does probiotic microorganism lactobacillus reuteri prevents allergic rhinitis and rhinoconjunctivitis development in children
-
Molecular sensitization profiles and clinical characteristics of seasonal allergic rhinitis in seven mediterranean countries: The @IT2020 multicenter study
-
Genome-wide association studies on individuals from han chinese background reveal novel genes as potential risk factors for allergic rhinitis
-
Probiotic NVP-1703 alleviates perennial allergic rhinitis by inducing IL-10 expression: A four-weeks, multi-center, double-blind, randomized, placebo-controlled clinical trial
-
A post hoc analysis of dupilumab efficacy in asthma patients with comorbid allergic rhinitis and chronic rhinosinusitis/nasal polyps from the LIBERTY ASTHMA QUEST study
-
Personal Allergy Tracker (PAT): Description of a study protocol utilizing m-Health technology for monitoring allergic rhinitis Can mobile technology improve control?
-
Food allergy - the beginners guide
-
Allergy to Kale
-
Exercise: induced asthma and rhinitis
-
Novel cell based assays in allergy diagnostics
-
How do allergens sensitize?
-
The dilemma of food allergy additives
-
Delabelling adults
-
Bronchial allergen challenge in research
-
An update on prevention of allergic diseases
-
Chronic rhinosinusitis with nasal polyps
-
Molecular allergology in daily clinical practice
-
B cells in in chronic rhinosinusitis: friend or foe
-
Oral food challenges thresholds for clinical reactions
-
Role Viral reactivations
-
Real-life evidence of the burden of chronic rhinosinusitis (CRS)
-
Epithelial cell barrier and allergic diseases
-
Severe cutaneous allergic reactions: searching for the culprit drug
-
Psychological support to peanut allergic children and their families
-
Asma e alergia em pandemia
-
Tree nut allergy: path from national to global data
-
Over-the-counter allergy prevention weaning products
-
Food allergy: new allergens on the block
-
Endotype-driven treatment in chronic rhinosinusitis
-
Can group consultations work in allergy? Learning from rheumatology
-
The ‘allergy tool kit’ for the transition clinic
-
Update on drug allergy
-
AIT in the pediatric population
-
Bronchial allergen challenge in the clinic
-
Covid-19 in "Allergy" journal
-
Cow’s milk protein-induced allergic proctocolitis: cohort review
-
Electronic Health in Severe Asthma
-
Nasal allergen challenge
-
Danger signs
-
Telemedicine and Tele-health
-
Evidence of immunotherapy on allergy prevention?
-
Paediatric multisystem allergy: a new diagnostic and severity score
-
Differential diagnosis
-
Dupilumab in paediatric patients with eosinophilic esophagitis
-
Launch of the Biological guidelines
-
Early biomarkers for severe drug hypersensitivity reactions
-
Social media and Allergies: how can we support our patients?
-
Difficult to control asthma in adults
-
Measles infection causes immune amnesia
-
Asma e alergia em Angola
-
Pediatric Covid-19 highlights published in PAI in 2020
-
Impact of food allergy on household expenditures among Manitoba families
-
Novel insight into development of allergic diseases
-
Tackling anaphylaxis
-
Implementing component resolved diagnostics in allergy diagnosis
-
Structural biology of food allergens and cross reactivity
-
Viral infection and asthma
-
The engineering-medicine interface
-
Hypereosinophilic syndromes and autoimmunity
-
Skin care from birth for allergy prevention: results today
-
Treating allergic patients during the COVID-19 pandemic
-
Elderly asthma
-
When to suspect allergic contact dermatitis in atopic dermatitis patients
-
Living with food allergy
-
BAT as a diagnostic tool in allergy to lipid transfer proteins (LTP)
-
Epitope mapping of the major allergen 2S albumin from pine nut
-
An update on food allergy
-
Prevention of food allergy: where are we now?
-
Novel approaches of allergen immunotherapy
-
-
